-
1دورية أكاديمية
المؤلفون: McDermott, David F, Huseni, Mahrukh A, Atkins, Michael B, Motzer, Robert J, Rini, Brian I, Escudier, Bernard, Fong, Lawrence, Joseph, Richard W, Pal, Sumanta K, Reeves, James A, Sznol, Mario, Hainsworth, John, Rathmell, W Kimryn, Stadler, Walter M, Hutson, Thomas, Gore, Martin E, Ravaud, Alain, Bracarda, Sergio, Suárez, Cristina, Danielli, Riccardo, Gruenwald, Viktor, Choueiri, Toni K, Nickles, Dorothee, Jhunjhunwala, Suchit, Piault-Louis, Elisabeth, Thobhani, Alpa, Qiu, Jiaheng, Chen, Daniel S, Hegde, Priti S, Schiff, Christina, Fine, Gregg D, Powles, Thomas
المصدر: Nature Medicine. 24(6)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Kidney Disease, Cancer, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Carcinoma, Renal Cell, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Kaplan-Meier Estimate, Kidney Neoplasms, Male, Middle Aged, Mutation, Sunitinib, Treatment Outcome, Medical and Health Sciences, Biomedical and clinical sciences, Health sciences
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/2f77r70pTest
-
2دورية أكاديمية
المؤلفون: Motzer, Robert, Alekseev, Boris, Rha, Sun-Young, Porta, Camillo, Eto, Masatoshi, Powles, Thomas, Grünwald, Viktor, Hutson, Thomas E, Kopyltsov, Evgeny, Méndez-Vidal, MarÃa J, Kozlov, Vadim, Alyasova, Anna, Hong, Sung-Hoo, Kapoor, Anil, Alonso Gordoa, Teresa, Merchan, Jaime R, Winquist, Eric, Maroto, Pablo, Goh, Jeffrey C, Kim, Miso, Gurney, Howard, Patel, Vijay, Peer, Avivit, Procopio, Giuseppe, Takagi, Toshio, Melichar, Bohuslav, Rolland, Frederic, De Giorgi, Ugo, Wong, Shirley, Bedke, Jens, Schmidinger, Manuela, Dutcus, Corina E, Smith, Alan D, Dutta, Lea, Mody, Kalgi, Perini, Rodolfo F, Xing, Dongyuan, Choueiri, Toni K, Galamaga, Rob
المصدر: ENT and Skull Base Surgery
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Renal Cell, Everolimus, Female, Humans, Kidney Neoplasms, Male, Middle Aged, Phenylurea Compounds, Programmed Cell Death 1 Receptor, Progression-Free Survival, Protein Kinase Inhibitors, Quinolines, Sunitinib, Survival Analysis
الإتاحة: https://doi.org/10.1056/NEJMoa2035716Test
https://scholar.barrowneuro.org/ent-and-skull-base-surgery/23Test -
3
المؤلفون: Choueiri, Toni K., Escudier, Bernard, Powles, Thomas, Tannir, Nizar M., Mainwaring, Paul N., Rini, Brian I., Hammers, Hans J., Donskov, Frede, Roth, Bruce J., Peltola, Katriina, Lee, Jae Lyun, Heng, Daniel Y. C., Schmidinger, Manuela, Agarwal, Neeraj, Sternberg, Cora N., McDermott, David F., Aftab, Dana T., Hessel, Colin, Old, Christian Scheff, Schwab, Gisela, Hutson, Thomas E., Pal, Sumanta, Motzer, Robert J., METEOR Investigators
المساهمون: Department of Oncology, Clinicum
المصدر: Translational Andrology and Urology
Choueiri, T K, Escudier, B, Powles, T, Tannir, N M, Mainwaring, P N, Rini, B I, Hammers, H J, Donskov, F, Roth, B J, Peltola, K, Lee, J L, Heng, D Y C, Schmidinger, M, Agarwal, N, Sternberg, C N, McDermott, D F, Aftab, D T, Hessel, C, Scheffold, C, Schwab, G, Hutson, T E, Pal, S, Motzer, R J & METEOR Investigators 2016, ' Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial ', The Lancet Oncology, vol. 17, no. 7, pp. 917-27 . https://doi.org/10.1016/S1470-2045Test(16)30107-3مصطلحات موضوعية: Male, 0301 basic medicine, Pyridines, law.invention, chemistry.chemical_compound, TARGETED THERAPY, PROGNOSTIC-FACTORS, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Anilides, Hazard ratio, Middle Aged, Prognosis, CANCER, Kidney Neoplasms, 3. Good health, Survival Rate, Editorial, Oncology, 030220 oncology & carcinogenesis, SURVIVAL, Female, medicine.drug, Sorafenib, medicine.medical_specialty, Cabozantinib, 3122 Cancers, Urology, 03 medical and health sciences, medicine, Humans, Everolimus, COMBINATION, Carcinoma, Renal Cell, Survival rate, Aged, Neoplasm Staging, III TRIAL, business.industry, EAU GUIDELINES, EFFICACY, Interim analysis, Surgery, SORAFENIB, 030104 developmental biology, chemistry, METASTASIS, business, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4bc4d936baaba5695527e426e9f6234Test
https://doi.org/10.1016/s1470-2045Test(16)30107-3 -
4دورية أكاديمية
المؤلفون: Choueiri, Toni K, Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N, Rini, Brian I, Donskov, Frede, Hammers, Hans, Hutson, Thomas E, Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J, Bjarnason, Georg A, Géczi, Lajos, Keam, Bhumsuk, Maroto, Pablo, Heng, Daniel Y C, Schmidinger, Manuela, Kantoff, Philip W, Borgman-Hagey, Anne, Hessel, Colin, Scheffold, Christian, Schwab, Gisela M, Tannir, Nizar M, Motzer, Robert J, Schöffski, Patrick
مصطلحات موضوعية: Adult, Aged, 80 and over, Anilides, Antineoplastic Agents, Carcinoma, Renal Cell, Disease-Free Survival, Everolimus, Female, Humans, Kidney Neoplasms, Male, Middle Aged, Pyridines, Quality of Life, Sirolimus, Survival Analysis
وصف الملف: 545699 bytes; application/pdf
العلاقة: New England Journal of Medicine vol:373 issue:19 pages:1814-23; https://lirias.kuleuven.be/handle/123456789/540820Test; https://lirias.kuleuven.be/bitstream/123456789/540820/1//Cabozantinib+versus+Everolimus+in+Advanced+Renal-Cell+Carcinoma.pdfTest
الإتاحة: https://lirias.kuleuven.be/handle/123456789/540820Test
https://lirias.kuleuven.be/bitstream/123456789/540820/1//Cabozantinib+versus+Everolimus+in+Advanced+Renal-Cell+Carcinoma.pdfTest -
5دورية أكاديمية
المؤلفون: Hutson, Thomas E., Davis, Ian D., Machiels, Jean-Pascal, De Souza, Paul L., Rottey, Sylvie, Hong, Bao-Fa, Epstein, Richard J, Baker, Katherine L, McCann, Lauren, Crofts, Theresa, Pandite, Lini, Figlin, Robert A
المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Unité d'oncologie médicale
المصدر: Journal of Clinical Oncology, Vol. 28, no. 3, p. 475-480 (2010)
مصطلحات موضوعية: Treatment Outcome, Sulfonamides, Pyrimidines, Middle Aged, Male, Kidney Neoplasms, Humans, Female, Carcinoma, Renal Cell, Antineoplastic Agents, Angiogenesis Inhibitors, Aged, 80 and over, Adult
العلاقة: boreal:28890; http://hdl.handle.net/2078.1/28890Test; info:pmid/20008644; urn:ISSN:0732-183X; urn:EISSN:1527-7755